#medical technology #Galien Foundation #Prix Galien

The Galien Foundation Unveils 2025 Prix Galien Bridges Awards Nominees

The Galien Foundation has recently announced the nominees for the inaugural 2025 Prix Galien Bridges Awards, aiming to highlight organizations and products that significantly elevate global health and innovation in life sciences. The awards ceremony is set to take place on December 5, 2025, at the Nobel Forum, situated on the Solna campus of Karolinska Institutet in Stockholm, Sweden. This event symbolizes the culmination of collaborative efforts aimed at addressing global health challenges and promoting scientific breakthroughs.

Emphasizing Global Collaboration

These prestigious awards include categories such as "Best Bridge-Builder Institution," "Best Biomedical Product," and "Best Medical Technology/AI Advances in Human Health," among others. The aim is to recognize the extraordinary contributions that stem from the Nordic innovation ecosystem, which is expanding to incorporate five additional countries: Austria, Israel, The Netherlands, Portugal, and Spain, collectively termed as the Nordics+ group.

Mikael Dolsten, Chair of the Prix Galien Bridges Committee, expressed his pride in the nominees, stating, "Their groundbreaking contributions reflect the strength of the Nordics+ ecosystem and its partners, advancing scientific progress and forging new pathways to improve health around the world." Each nominee is evaluated for its potential to improve patient outcomes, healthcare delivery, or scientific understanding, with an emphasis on advancements that foster collaboration across borders.

Nominees Across Various Categories

Best Bridge-Builder Institution

The nominees for the "Best Bridge-Builder Institution" category include:

• - Centre for Research Equity, Nuffield Department of Primary Care Health Sciences, University of Oxford
• - Coalition for Epidemic Preparedness Innovations (CEPI)
• - European and Developing Countries Clinical Trials Partnership (EDCTP)
• - NurExone Biologic Ltd

Best Biomedical Product

In the "Best Biomedical Product" category, three innovative products have been nominated:

• - Greywolf Therapeutics for GRWD5769
• - Idorsia Pharmaceuticals Nordics AB for QUVIVIQ
• - Sun Pharma for UNLOXCYT (cosibelimab-ipdl)

Best Medical Technology/AI Advances in Human Health

This category acknowledges advancements in medical technologies and AI, with nominees including:

• - Clinigma for Clinigma Portal
• - Evaxion for AI-Immunology™ platform
• - Grifols for sCD38
• - Roche Diagnostics for cobas® i 601 analyzer and Ionify® assays
• - Smartcella for Extroducer

Best Product for Rare/Orphan Diseases

In the fight against rare diseases, the following products are recognized:

• - F. Hoffmann-La Roche Ltd for EVRYSDI®
• - Immunocore for KIMMTRAK
• - Krystal Biotech for Vyjuvek
• - Novo Nordisk for Alhemo®
• - Servier Pharmaceuticals for VORANIGO®

Best Public Sector Innovation

Lastly, the nominees for public sector innovation are:

• - Bavarian Nordic for JYNNEOS (MVA-BN) mpox and smallpox vaccine
• - HISP Centre, University of Oslo for DHIS2
• - Pediatric Praziquantel Consortium for Arpraziquantel
• - PATH for MenAfriVac

New Award for Scientific Integrity

In addition to the awards, the committee has introduced the Bengt I. Samuelsson